<!DOCTYPE html>
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>

    <!-- Basic Page Needs
  ================================================== -->
	<meta charset="utf-8">
	<title>Times of Neurology</title>
	<meta name="description" content="Newsletter, Neurology,Epilepsy Designed by Medeka | medekahealth.com">
	<meta name="author" content="Neurology,Epilepsy">
	
    <!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    
    <!-- CSS
  ================================================== -->
  	<link rel="stylesheet" href="css/zerogrid.css">
	<link rel="stylesheet" href="css/style.css">
    <link rel="stylesheet" href="css/responsive.css">
	<link rel="stylesheet" href="css/responsiveslides.css" />
	
	<!--[if lt IE 8]>
       <div style=' clear: both; text-align:center; position: relative;'>
         <a href="http://windows.microsoft.com/en-US/internet-explorer/products/ie/home?ocid=ie6_countdown_bannercode">
           <img src="http://storage.ie6countdown.com/assets/100/images/banners/warning_bar_0000_us.jpg" border="0" height="42" width="820" alt="You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today." />
        </a>
      </div>
    <![endif]-->
    <!--[if lt IE 9]>
		<script src="js/html5.js"></script>
		<script src="js/css3-mediaqueries.js"></script>
	<![endif]-->
	
	<link href='./images/ton.ico' rel='icon' type='image/x-icon'/>
    <script src="js/jquery.min.js"></script>
	<script src="js/responsiveslides.js"></script>
	<script>
		$(function () {
		  $("#slider").responsiveSlides({
			auto: true,
			pager: false,
			nav: true,
			speed: 500,
			maxwidth: 962,
			namespace: "centered-btns"
		  });
		});
	</script>
	
	
</head>
<body>
<!--------------Header--------------->
<header>
	<div class="subnav">
		<div class="wrap-subnav zerogrid">
			<div class="links">
				<ul>
					<li><a href="index.html">Home</a></li>
					<li><a href="aboutus.html">About</a></li>
					<li><a href="contact.html">Contact</a></li>
				</ul>
			</div>
		</div>
	</div>
	<div class="wrap-header zerogrid">
		<div id="logo"><a href="#"><img src="./images/logo.png"/></a></div>
</header>

<nav>
	<div class="wrap-nav zerogrid">
		<div class="menu">
	<ul>
		<li><a href="SV.html">Sodium Valproate</a></li>
		<li><a href="DP.html">Clobazam</a></li>
		<li><a class="current" href="OXCB.html">Oxcarbazepine</a></li>
        <li><a  href="OXCB_PM.html">Pregabalin</a></li>
        <li><a href="NN.html">Neurology News</a></li>        
	</ul>
		</div>
		
		<div class="minimenu"><div>TOPICS</div>
			<select onchange="location=this.value">
            <option value="index.html">Home</option>
				<option value="SV.html">Sodium Valproate</option>
				<option value="DP.html">Clobazam</option>
           		<option value="OXCB_HM.html">Hospital Coverage </option>     
				<option value="OXCB.html">Oxcarbazepine</option>
                <option value="OXCB_PM.html">Pregabalin</option>
                <option value="EXPO.html">Disease Perspective</option>
                <option value="NN.html">Neurology News</option>
                <option value="quiz.html">Neurology Quiz</option>
			</select>
		</div>
	</div>
</nav>

<!--------------Content--------------->
<section id="content">
	<div class="wrap-content zerogrid">
	  <div class="row">
		  <div id="main-content" class="col-2-3">
            <div class="wrap-col">
					<article>
					<h2h><a href="OXCB.html">Oxcarbazepine</a></h2h>
                    <br>
					 <ul><li><h2><a href="OXCB.html">Oxcarbazepine: A valuable treatment option for partial-onset seizures in children</a></h2>
						<span class="info">by medeka healthcare on october 01, 2013</a></span></li></ul>

			  </article>
					<article>
					   <h11>References</h11>
                       <ol>
                            <li>Friedman MJ, Sharieff GQ. Seizures in Children. Pediatr Clin N Am. 2006;53:257–77.</li>
                            <li>Arya R, Glauser TA. Pharmacotherapy of focal epilepsy in children: A systematic review of approved agents. CNS Drugs. 2013;27(4):273–86.</li>
                            <li>Kalis MM, Huff NA. Oxcarbazepine, an antiepileptic agent. Clin Ther. 2001;23(5):680–700. </li> 
<li>Schmidt D, Elger CE. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Epilepsy Behav,2004;5(5):627–35.</li>
<li>Beydoun A. Safety and efficacy of oxcarbazepine: Results of randomized, double-blind trials. Pharmacotherapy. 2000;20(8 Pt 2):152S–158S.</li>
<li>Belousova ED, Mukhin KIu, Ermolenko NA, et al. Efficacy and safety of the monotherapy with trileptal (oxcarbazepine) in children and adolescents [Article in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(5 Pt 1):45–50.</li>
<li>Eun SH, Kim HD, Chung HJ, et al. A multicenter trial of oxcarbazepine oral suspension monotherapy in children newly diagnosed with partial seizures: A clinical and cognitive evaluation. Seizure. 2012;21(9):679–84.</li>
<li>Piña-Garza JE, Espinoza R, Nordli D, et al. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology. 2005;65(9):1370–5.</li>
<li>Kothare SV, Khurana DS, Mostofi N, et al. Oxcarbazepine monotherapy in children and adolescents: A single-center clinical experience. Pediatr Neurol. 2006;35(4):235–9.</li> 
<li>Northam RS, Hernandez AW, Litzinger MJ, et al. Oxcarbazepine in infants and young children with partial seizures. Pediatr Neurol. 2005;33(5):337–44.</li>
<li>Sachdeo RC, Gates JR, Bazil CW, et al. Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy. Epilepsy Behav. 2006;9(3):457–63. </li>
<li>Donati F, Gobbi G, Campistol J, et al. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure. 2007;16(8):670–9.</li>
<li>Naik N, Gawai A. Efficacy, safety and tolerability of Trioptal® (oxcarbazepine) in children and adolescents with newly diagnosed partial seizures or generalized tonic-clonic seizures: Results of a 6 months, prospective, open-label, multicentre, non-comparative, observational post-marketing surveillance study. Indian medical gazette- August 2012. Available on http://medind.nic.in/ice/t12/i8/icet12i8p324.pdf. Accessed on July 22<sup>nd</sup>, 2013.
</li></ol></article>
					<ul id="pagi">
						<li><a href="OXCB-I.html">1</a></li>
						<li><a href="OXCB-II.html">2</a></li>
                        <li><a href="OXCB-III.html">3</a></li>
                        <li><a href="OXCB-IV.html">4</a></li>
                        <li><a class="current" href="OXCB-V.html">5</a></li>
					</ul>
					
		    </div>
         <p><br>
            <div class="featured">
	<div class="wrap-col">
		<div class="slider">
			<div class="rslides_container">
				<ul class="rslides" id="slider">
					<li><img src="images/slide05.jpg"/></li>
					<li><img src="images/slide15.jpg"/></li>
                  
				</ul>
			</div>
		</div>
	</div>
</div>   
            
	    </div>
			<div id="sidebar" class="col-1-3">
				<div class="wrap-col">
                <div class="box">
					  <div class="heading">
					    <h2>Contents</h2></div>
						<div class="content">
							<div class="linklist">
							  <ul><li><a href="IM.html">Initial monotherapy with levetiracetam fails more
frequently than monotherapy with valproate or
oxcarbazepine:</a>An enlightening evidence</li>
									<li><a href="SVpage_1.html">Sodium valproate:</a>A gold standard for the treatment of
childhood epilepsy</li>
									<li><a href="SVpage_2.html">Superior efficacy of sodium valproate IV reported in</a> acute seizures and status epilepticus</li>
									<li><a href="DP.html">Clobazam: </a>An effective long-term treatment option
for Lennox-Gastaut syndrome</li>
                                    <li><a href="OXCB_HM.html">Hospital coverage:</a>Krishna Institute of Medical Sciences</li>
                                <li><a href="OXCB.html">Oxcarbazepine:</a>A valuable treatment option for
partial-onset seizures in children</li>
                                      <li><a href="OXCB_PM.html">Pregabalin and methylcobalamin combination for
neuropathic pain:</a>The Indian scenario</li>
                                <li><a href="EXPO.html">Important aspects of epilepsy management:</a>during pregnancy</li>
                                    <li><a href="NN.html">Neurology News</a></li>
                                    <li><a href="quiz.html">Neurology Quiz</a></li>
                                    
								</ul>
							</div>
						</div>
				  </div>
                  <div class="box">
						<div class="heading"><h2>News Digest</h2></div>
						<div class="content">
							<div class="posts">
								<img src="images/post01.png"/>
								<h4><a href="#">ECG should be considered
in patients with refractory
epilepsy</a></h4><br>
									<p>Analysis of electrocardiogram
(ECG) monitoring
in patients with refractory
epilepsy revealed significant differences in
heart rate between ictal and pre-ictal states,
between ictal and post-ictal states, and
between pre- and post-ictal states. Hence,
ECG might be helpful to detect serious
cardiac abnormalities in patients with
refractory epilepsy.</p><p class="sideref">J Res Med Sci. 2013;18(Suppl 1):S32–4.</p>
							</div>
							<div class="posts">
								<img src="images/post02.png"/>
								<h4><a href="#">Use of gabapentin in pregnancy is not associated with increased risk of major malformations</a></h4><br>
							<p>A prospective study of
pregnancy outcomes in
223 pregnant women who were exposed to gabapentin and 223 pregnant women who were unexposed to gabapentin reported
that gabapentin use in pregnancy was not associated with increased risk for major malformations.</p> <p class="sideref">Epilepsy Behav. 2013;26(1):109–13.</p>
							</div>
							<div class="posts">
								<img src="images/post03.png"/>
								<h4><a href="#">A portable automatic device for the detection of generalized tonicclonic seizures</a></h4>
							<p>Increased S100B protein levels in cerebrospinal fluid may be associated with the neuronal damage following central nervous infections.</p>
							<p class="sideref">Epilepsia. 2013;54(4):e58–61.</p></div>
						</div>
				  </div>
					<div class="box">
						<div class="heading">
						  <h2>Updates</h2></div>
						<div class="content"> <img src="images/updates_add01.gif"/>						  <img src="images/updates_add02.gif"/>
						</div>
					</div>
				</div>
			</div>
	  </div>
  </div>
</section>
<!--------------Footer--------------->
<footer>
	<div class="copyright">
		<p>Copyright © 2013 Medekahealth.com - All rights reserved. | Design: <a href="http://www.medekahealth.com/">MedekaHealth.com</a><a href=</p>
	</div>
</footer>

</body></html>